Suchergebnisse - "Zanuso, Valentina"

PubPharm (21)

1

The rapidly evolving landscape of HCC : Selecting the optimal systemic therapy

enthalten in: Hepatology (Baltimore, Md.) | 2023

von Zanuso, V. | Rimassa, L. | Braconi, C.

2

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer : An early exploratory analysis of real-world data

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2023

von Rimini, M. | Fornaro, L. | Lonardi, S. | +37

CommentIn: Liver Int. 2023 Aug;43(8):1620-1622. - PMID 37452502

3

Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma

enthalten in: Hepatology international | 2023

von Vithayathil, M. | D'Alessio, A. | Fulgenzi, C. | +32

CommentIn: Hepatol Int. 2023 Aug;17(4):827-829. - PMID 37188999

4

Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma

enthalten in: Hepatology international | 2023

von Vithayathil, M. | D’Alessio, A. | Fulgenzi, C. | +32

5

Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma

enthalten in: Hepatology international | 2023

von Vithayathil, M. | D’Alessio, A. | Fulgenzi, C. | +32

6

Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma

enthalten in: Hepatology international | 2023

von Vithayathil, M. | D’Alessio, A. | Fulgenzi, C. | +32

7

Pancreatic Ductal Adenocarcinoma and Immune Checkpoint Inhibitors : The Gray Curtain of Immunotherapy and Spikes of Lights

enthalten in: Current oncology (Toronto, Ont.) | 2023

von Balsano, R. | Zanuso, V. | Pirozzi, A. | +2

8

Safety and Efficacy of Atezolizumab and Bevacizumab Combination as a First Line Treatment of Advanced Hepatocellular Carcinoma

enthalten in: Journal of hepatocellular carcinoma | 2023

von Zanuso, V. | Pirozzi, A. | Balsano, R. | +2

9

Updated survival outcomes with ivosidenib in patients with previously treated IDH1-mutated intrahepatic-cholangiocarcinoma : an Italian real-world experience

enthalten in: Therapeutic advances in medical oncology | 2023

von Rimini, M. | Burgio, V. | Antonuzzo, L. | +15

10

Immunotherapy in hepatocellular carcinoma : how will it reshape treatment sequencing?

enthalten in: Therapeutic advances in medical oncology | 2023

von Cammarota, A. | Zanuso, V. | Manfredi, G. | +3